- Home
- ACHV vs NUKK Comparison
ACHV vs NUKK Comparison
Compare ACHV & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- NUKK
- Stock Information
- Founded
- ACHV N/A
- NUKK 2013
- Country
- ACHV United States
- NUKK United States
- Employees
- ACHV N/A
- NUKK N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NUKK Blank Checks
- Sector
- ACHV Health Care
- NUKK Finance
- Exchange
- ACHV Nasdaq
- NUKK Nasdaq
- Market Cap
- ACHV 72.5M
- NUKK 77.4M
- IPO Year
- ACHV N/A
- NUKK N/A
- Fundamental
- Price
- ACHV $2.23
- NUKK $11.11
- Analyst Decision
- ACHV Strong Buy
- NUKK
- Analyst Count
- ACHV 3
- NUKK 0
- Target Price
- ACHV $14.33
- NUKK N/A
- AVG Volume (30 Days)
- ACHV 1.2M
- NUKK 584.3K
- Earning Date
- ACHV 08-12-2025
- NUKK 07-07-2025
- Dividend Yield
- ACHV N/A
- NUKK N/A
- EPS Growth
- ACHV N/A
- NUKK N/A
- EPS
- ACHV N/A
- NUKK N/A
- Revenue
- ACHV N/A
- NUKK N/A
- Revenue This Year
- ACHV N/A
- NUKK N/A
- Revenue Next Year
- ACHV N/A
- NUKK N/A
- P/E Ratio
- ACHV N/A
- NUKK N/A
- Revenue Growth
- ACHV N/A
- NUKK N/A
- 52 Week Low
- ACHV $1.84
- NUKK $1.30
- 52 Week High
- ACHV $5.31
- NUKK $78.32
- Technical
- Relative Strength Index (RSI)
- ACHV 33.69
- NUKK 41.16
- Support Level
- ACHV $2.00
- NUKK $9.90
- Resistance Level
- ACHV $3.90
- NUKK $11.35
- Average True Range (ATR)
- ACHV 0.29
- NUKK 1.28
- MACD
- ACHV -0.18
- NUKK -0.05
- Stochastic Oscillator
- ACHV 8.91
- NUKK 10.98
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).